Exploring the mechanism of action of Yiyi Fuzi Baijiang powder in colorectal cancer based on network pharmacology and molecular docking studies

References

• Arnold, M., Sierra, M. S., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2016). Global patterns and trends in colorectal cancer incidence and mortality. Gut, 66(4), 683–691. https://doi.org/10.1136/gutjnl-2015-310912
   PubMed Web of Science ®Google Scholar
• Backhouse, N., Rosales, L., Apablaza, C., Goïty, L., Erazo, S., Negrete, R., Theodoluz, C., Rodríguez, J., & Delporte, C. (2008). Analgesic, anti-inflammatory and antioxidant properties of Buddleja globosa, Buddlejaceae. Journal of Ethnopharmacology, 116(2), 263–269. https://doi.org/10.1016/j.jep.2007.11.025
   PubMed Web of Science ®Google Scholar
• Bae, H., Song, G., & Lim, W. (2020). Stigmasterol causes ovarian cancer cell apoptosis by inducing endoplasmic reticulum and mitochondrial dysfunction. Pharmaceutics, 12(6), 488. https://doi.org/10.3390/pharmaceutics12060488
   PubMed Web of Science ®Google Scholar
• Baskar, A. A., Ignacimuthu, S., Paulraj, G. M., & Al Numair, K. S. (2010). Chemopreventive potential of β-Sitosterol in experimental colon cancer model - an in vitro and in vivo study. BMC Complementary and Alternative Medicine, 10(1). https://doi.org/10.1186/1472-6882-10-24
   PubMed Web of Science ®Google Scholar
• Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Chen, A. Y., & Chen, Y. C. (2013). A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chemistry, 138(4), 2099–2107. https://doi.org/10.1016/j.foodchem.2012.11.139
   PubMed Web of Science ®Google Scholar
• Dilixia-Shima, Y., Li, F., & Zhang, W. J. (2012). The relationship between IL-17 structure and its signaling pathway and tumor. Agricultural Medicine, 34(02), 166–171.
   Google Scholar
• Du, L., Kim, J. J., Shen, J., Chen, B., & Dai, N. (2017). KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: A meta-analysis. Oncotarget, 8(13), 22175–22186. https://doi.org/10.18632/oncotarget.14549
   PubMedGoogle Scholar
• Du, Y., Zemin, W., & Dianrong, L. (2015). 33 cases of colorectal cancer treated with combined chemotherapy with Yiyi Fuzi Baijiang powder. Chinese Traditional Medicine Science and Technology, 22(02), 213–214.
   Google Scholar
• Fang, J., Chen, J., & Jin, Y. (2018). A review of clinical applications and research of Yiyi Fuzi Baijiang powder. Shaanxi Traditional Chinese Medicine, 39(03), 383–386.
   Google Scholar
• Gupta, S. C., Tyagi, A. K., Deshmukh-Taskar, P., Hinojosa, M., Prasad, S., & Aggarwal, B. B. (2014). Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols. Archives of Biochemistry and Biophysics, 559, 91–99. https://doi.org/10.1016/j.abb.2014.06.006
   PubMed Web of Science ®Google Scholar
• Hsin, K. -Y., Ghosh, S., Kitano, H., & Fraternali, F. (2013). Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology. Plos One, 8(12), e83922. https://doi.org/10.1371/journal.pone.0083922
   PubMed Web of Science ®Google Scholar
• Hu, Y., Chen, X., Li, Z., Zheng, S., & Cheng, Y. (2020). Thermosensitive in situ gel containing luteolin micelles is a promising efficient agent for colorectal cancer peritoneal metastasis treatment. Journal of Biomedical Nanotechnology, 16(1), 54–64. https://doi.org/10.1166/jbn.2020.2870
   PubMed Web of Science ®Google Scholar
• Hu, S., Yuan, J., Xu, J., Li, X., Zhang, G., Ma, Q., Zhang, B., Hu, T., & Song, G. (2019). TNF-α and IFN-γ synergistically inhibit the repairing ability of mesenchymal stem cells on mice colitis and colon cancer. American Journal of Translational Research, 11(9), 6207–6220. https://pubmed.ncbi.nlm.nih.gov/31632588/
   PubMed Web of Science ®Google Scholar
• Kolls, J. K., & Lindén, A. (2004). Interleukin-17 family members and inflammation. Immunity, 21(4), 467–476. https://doi.org/10.1016/j.immuni.2004.08.018
   PubMed Web of Science ®Google Scholar
• Lee, H., Cho, H., Yu, R., Lee, K., Chun, H., & Park, J. (2014). Mechanisms underlying apoptosis-inducing effects of kaempferol in HT-29 human colon cancer cells. International Journal of Molecular Sciences, 15(2), 2722–2737. https://doi.org/10.3390/ijms15022722
   PubMed Web of Science ®Google Scholar
• Li, Q. (2016). Inhibition of colorectal cancer growth by kaempferol combined with 5-fluorouracil and its mechanism. Fujian University of Traditional Chinese Medicine.
   Google Scholar
• Li, D., Wang, G., Jin, G., Yao, K., Zhao, Z., Bie, L., Guo, Y., Li, N., Deng, W., Chen, X., Chen, B., Liu, Y., Luo, S., & Guo, Z. (2018). Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2018.3969
   Web of Science ®Google Scholar
• Li, J., Yang, Z., Long, F. X., Wang, J. H., Guo, B., Chen, J., Wang, Q., & Tang, D. X. (2017). Examples of medical cases of Yiyi Fuzi Baijiang powder by Professor Liu Shangyi, a master of national medicine. Journal of Chengdu University of Traditional Chinese Medicine, 40(04), 66–68. https://doi.org/10.13593/j.cnki.51-1501/r.2017.04.066
   Google Scholar
• Li, X. -L., Zhou, J. -B., Chen, Z. -R., & Chng, W. -J. (2015). P53 mutations in colorectal cancer- molecular pathogenesis and pharmacological reactivation. World Journal of Gastroenterology, 21(1), 84. https://doi.org/10.3748/wjg.v21.i1.84
   PubMed Web of Science ®Google Scholar
• Malki, A., ElRuz, R. A., Gupta, I., Allouch, A., Vranic, S., & Al Moustafa, A. -E. (2020). Molecular mechanisms of colon cancer progression and metastasis: Recent insights and advancements. International Journal of Molecular Sciences, 22(1), 130. https://doi.org/10.3390/ijms22010130
   PubMed Web of Science ®Google Scholar
• MA, X., & Y, BAI (2012). IGF-1 activates the P13K/AKT signaling pathway via upregulation of secretory clusterin. Molecular medicine reports, 6(6), 1433–1437. https://doi.org/10.3892/mmr.2012.1110
   PubMed Web of Science ®Google Scholar
• Meng, X., Zhong, W. Q., & Zhang, X. R. (2017). Experimental study on the inhibition of proliferation, migration and epithelial mesenchymal transformation of colon cancer HT-29 cells by luteolin. Journal of Hainan Medical College, 23(21), 2903–2905+2909.
   Google Scholar
• Mutoh, M., Takahashi, M., Fukuda, K., Matsushima-Hibiya, Y., Mutoh, H., Sugimura, T., & Wakabayashi, K. (2000). Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. Carcinogenesis, 21(5), 959–963. https://doi.org/10.1093/carcin/21.5.959
   PubMed Web of Science ®Google Scholar
• Nakayama, M., Sakai, E., Echizen, K., Yamada, Y., Oshima, H., Han, T. -S., Ohki, R., Fujii, S., Ochiai, A., Robine, S., Voon, D. C., Tanaka, T., Taketo, M. M., & Oshima, M. (2017). Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation. Oncogene, 36(42), 5885–5896. https://doi.org/10.1038/onc.2017.194
   PubMed Web of Science ®Google Scholar
• Peng, J. Y. (2006). Study on the material basis, preparation process and pharmacodynamics of Yiyi Fuzi Baijiang powder. Second Military Medical University.
   Google Scholar
• Rauf A., Imran M., Khan I A., Mujeeb-Ur-Rehman, Gilani S A., Mehmood Z., & Mubarak M S. (2018). Anticancer potential of quercetin: A comprehensive review. Phytotherapy research, 32(11), 2109–2130. https://doi.org/10.1002/ptr.6155
   PubMed Web of Science ®Google Scholar
• Razi, S., Baradaran Noveiry, B., Keshavarz-Fathi, M., & Rezaei, N. (2019). IL-17 and colorectal cancer: From carcinogenesis to treatment. Cytokine, 116, 7–12. https://doi.org/10.1016/j.cyto.2018.12.021
   PubMed Web of Science ®Google Scholar
• Saikia, S., & Bordoloi, M. (2019). Molecular docking: Challenges, advances and its use in drug discovery perspective. Current drug targets, 20(5), 501–521. https://doi.org/10.2174/1389450119666181022153016
   PubMed Web of Science ®Google Scholar
• Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Sun, X., Pingping, C., & Yue, L. (2017). Advances in the study of antitumor action targets of natural flavonoids. Chinese Journal of Experimental Formulary, 23(06), 218–228.
   Google Scholar
• Sun, T., Zhu, T., Liang, X., Yang, S., & Zhao, R. (2018). Effects of recombinant circularly permuted tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) (recombinant mutant human TRAIL) in combination with 5-fluorouracil in human colorectal cancer cell lines HCT116 and SW480. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 24, 2550–2561. https://doi.org/10.12659/msm.909390
   PubMed Web of Science ®Google Scholar
• Suto, R., Tominaga, K., Mizuguchi, H., Sasaki, E., Higuchi, K., Kim, S., Iwao, H., & Arakawa, T. (2004). Dominant-negative mutant of c-Jun gene transfer: A novel therapeutic strategy for colorectal cancer. Gene Therapy, 11(2), 187–193. https://doi.org/10.1038/sj.gt.3302158
   PubMed Web of Science ®Google Scholar
• Szczuka, I., Wierzbicki, J., Serek, P., Szczęśniak-Sięga, B. M., & Krzystek-Korpacka, M. (2021). Heat shock proteins HSPA1 and HSP90AA1 are upregulated in colorectal polyps and can be targeted in cancer cells by anti-inflammatory oxicams with arylpiperazine pharmacophore and benzoyl moiety substitutions at thiazine ring. Biomolecules, 11(11), 1588. https://doi.org/10.3390/biom11111588
   PubMed Web of Science ®Google Scholar
• Tang, D. X., Yang, Z., & Liu, S. Y. (2016). Application of Liu Shangyi’s academic viewpoint of “drawing ulcers into tumors and treating from membranes” in the diagnosis and treatment of tumors. Journal of Traditional Chinese Medicine, 57(20), 1732–1734. https://doi.org/10.13288/j.11-2166/r.2016.20.006
   Google Scholar
• Ulusoy, H. G., & Sanlier, N. (2020). A mini review of quercetin: From its metabolism to possible mechanisms of its biological activities. Critical Reviews in Food Science and Nutrition, 60(19), 3290–3303. https://doi.org/10.1080/10408398.2019.1683810
   PubMed Web of Science ®Google Scholar
• Wang, S. H., & Yiyi, F. Z. (2017). Baijiang powder. Henan Traditional Chinese Medicine, 37(11), 1955.
   Google Scholar
• Yu, P. W., & Li, Z. Y. (2020). Current situation and reflection on the robotic gastric cancer surgery in China. Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery, 23(4), 332–335. https://doi.org/10.3760/cma.j.cn.441530-20200113-00020
   PubMedGoogle Scholar
• Zhang, W., Hart, J., McLeod, H. L., & Wang, H. L. (2005). Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms. American Journal of Clinical Pathology, 124(1), 11–19. https://doi.org/10.1309/t1h2y2chwy7pd2bn
   PubMed Web of Science ®Google Scholar
• Zhang, Y. Q., & Li, Z. (2015). Some advances in modern research on network pharmacology and Chinese medicine [J]. Chinese Journal of Pharmacology and Toxicology, 29(06), 883–892.
   Google Scholar
• Zhao, X., Liu, J., Liu, S., Yang, F., & Chen, E. (2019). Construction and validation of an immune-related prognostic model based on TP53 status in colorectal cancer. Cancers, 11(11), 1722. https://doi.org/10.3390/cancers11111722
   PubMed Web of Science ®Google Scholar
• Zhou, X.M. (2016). Effects of quercetin on proliferation and apoptosis of human ovarian cancer cells-3. Journal of Traditional Chinese Medicine, 31(07), 931–936.
   Google Scholar
• Zhou, Z., Chen, B., Chen, S., Lin, M., Chen, Y., Jin, S., Chen, W., & Zhang, Y. (2020). Applications of network pharmacology in traditional Chinese medicine research. Evidence-Based Complementary and Alternative Medicine, 2020, 1–7. https://doi.org/10.1155/2020/1646905
   Web of Science ®Google Scholar